Search clinical trials for: the split-thickness skin graft （STSG） donor site

Total 283925 results

Hobart W. Harris
Vitruvian Medical Devices, Inc.

Not yet recruiting

Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

Skin Graft Complications
Nanjing First Hospital, Nanjing Medical University

Recruiting

The Comparison of Thick Split-thickness Skin Graft Versus Thin Split-thickness Skin Graft

Reconstruction

China
Imbed Biosciences
Arizona Burn Center, Maricopa Medical Center (Phoenix, AZ)

Not yet recruiting

A Study to Evaluate the Efficacy of Microlyte Matrix in the Management of Donor Site Wounds

Wounds and Injuries
University Hospital, Montpellier

Recruiting

Evaluation of the PICO® Negative Pressure Dressing System on the Fibula Free Flap Donor Site's Skin Graft. (PICOFLAP)

Carcinomatous Resections | Violent Trauma

France
University of Kansas Medical Center

Recruiting

Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

Pain, Postoperative | Burns

United States
University of Arizona

Terminated

The Effect of Platelet Rich Plasma on Pain at Skin Graft Donor Sites

Skin Graft Complications | PRP | Skin Graft (Allograft) Rejection | Skin Graft Detachment

United States
Cairo University

Completed

Donor Site Healing Response to Low Level Laser Therapy Following Skin Graft Surgery

Skin Graft

Egypt
Acera Surgical, Inc.

Terminated

Utility of Restrata With Split Thickness Skin Graft to Reconstruct the Forearm Donor Site

Wound Heal

United States
Nanomedic Technologies Ltd.

Completed

Evaluation of the SPINNER Device for the Application of Wound Dressing: Treatment of Split Skin Graft Donor Sites (SPINNER01)

Wound of Skin

Israel
Nebraska Methodist Health System
Acera Surgical, Inc.

Terminated

Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site

Head and Neck Cancer

United States
Rambam Health Care Campus

Withdrawn

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site

Treatment of Skin Graft Donor Site

Israel
University of Alabama at Birmingham

Completed

Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites

Surgical Wound

United States
University of Colorado, Denver
Children's Hospital Colorado

Terminated

Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites (Suprathel)

Burns | Skin Graft Complications | Skin; Deformity

United States
University Hospital, Linkoeping

Completed

Scarring At Donor Sites After Split-Thickness Skin Graft.

Donor Site Complication

Sweden
HaEmek Medical Center, Israel

Unknown

The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site

Disorder of Skin Donor Site

Israel
Noveome Biotherapeutics, formerly Stemnion

Terminated

Study of ST266 in Diabetic Subjects With Deep Burns Managed With Skin Grafts

Diabetes | Third Degree Burns

United States
Birken AG

Completed

Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12) (BSG-12)

Wounds

Spain, France, Greece, Latvia
Mundipharma Korea Ltd

Completed

Compare of Petrolatum Gauze, Allevyn, and New Dressing, Betafoam® in the Management of Split-Thickness Skin Graft Donor Site

Skin Graft

Korea, Republic of
University Hospital, Rouen

Unknown

Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site (ROPI)

Graft Pain

France
Brigham and Women's Hospital

Withdrawn

Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites

Burns | Split-thickness Skin Graft Donor Sites
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Juvenile Myelomonocytic Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell... and other conditions

United States, Italy
Georgetown University

Withdrawn

Study Evaluating AWBAT-D Versus the Standard of Care of Split-thickness Skin Graft Donor Sites

Healing of Donor Site | Pain Level

United States
Massachusetts General Hospital

Completed

Ultrasound-Guided Block of the Lateral Femoral Cutaneous Nerve in Pediatric Patients

Burns

United States
Chulalongkorn University

Unknown

Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites

Wound | Disorder of Skin Donor Site

Thailand
Thrombotargets Europe S.L

Completed

Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting (EHTIC)

Burns | Traumatic Lesions

Spain
Ohio State University Comprehensive Cancer Center

Completed

Wound Dressings For Split-Thickness Skin Graft Donor Sites in Patients Undergoing Surgery

Pain | Perioperative/Postoperative Complications

United States
Children's Surgical Center, Cambodia

Unknown

Phenytoin in the Healing of Clean Surgical Wounds

Wound | Re-Epithelialization

Cambodia
Birken AG

Completed

Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Moist Wound Healing Dressing Alone in Accelerating the Epithelialization of Split Thickness Skin Graft Donor Sites (OleoSplit)

Accelerating the Epithelialization of Split Thickness Skin Graft

Germany
Celleration, Inc.

Completed

Split Thickness Donor Site Healing With MIST Study

Burns | Trauma | Venous Ulcers

United States
Tang-Du Hospital

Completed

Wound-healing Improvement by Resurfacing Split-Thickness Skin Donor Sites With Thin Split-thickness Grafting

Disorder of Skin Donor Site | Skin Graft Disorder | Wound Healing Disturbance of
Organogenesis

Terminated

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Wounds

Canada
Lee's Pharmaceutical Limited
Guangzhou First People's Hospital; Ruijin Hospital

Completed

Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites

Split-thickness Skin Graft Donor Sites
Aubrey Inc.

Unknown

Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery (AWBAT-D)

Treatment of Donor Site Burns

United States
Renovo

Completed

Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites

Cicatrix | Wound Healing

United Kingdom
Renovo

Completed

Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites

Trauma | Burn | Varicose Ulcer

United Kingdom, Russian Federation, Germany, Latvia
Renovo

Completed

Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor Sites

Wound

United Kingdom
Assiut University

Recruiting

Donor Site Morbidity After Free Vascularized Fibular Graft

Osteosarcoma

Egypt
Alfonso X El Sabio University

Not yet recruiting

Use of Cyanoacrylate in Healing and Pain in the Palatal Donor Site of Connective Tissue Grafts

Pain, Postoperative | Healing Surgical Wounds

Spain
I.M. Sechenov First Moscow State Medical University

Recruiting

Using of Collagen Matrix for Maxillary Tuberosity Donor Area Preservation

Soft Tissue Atrophy

Russian Federation
Margaret Gatti-Mays

Recruiting

Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | HER2-Negative Breast Carcinoma

United States
Fujian Medical University Union Hospital

Recruiting

Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds

Skin Wound | Scar, Hypertrophic

China
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer

Breast Cancer

China
AnaptysBio, Inc.

Recruiting

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).

Atopic Dermatitis Eczema

Georgia, United States, Australia, Canada, Czechia, New Zealand, Poland
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

Breast Cancer

United States, Puerto Rico
Assiut University

Not yet recruiting

Clinical Effectiveness of Polymethoxy Flavones Solid Dispersion as a Dressing Material for Palatal Grafts Donor Sites (RCT)

Gingival Recession | Soft Tissue Infections

Egypt
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast Carcinoma

United States, Puerto Rico
Cairo University

Recruiting

The Use of Flowable Resin Composite Stent in Reduction of Donor Site Morbidity After Free Gingival Graft Harvesting

Free Gingival Graft

Egypt
University of British Columbia

Recruiting

Radial Forearm Donor Site Closure

Oral Cancer | Oral Cavity Cancer | Donor Site Complication

Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Recruiting

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction... and other conditions

United States, Puerto Rico
Sanofi

Recruiting

A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)

Hemophilia

Greece, Korea, Republic of, France, Taiwan, Italy, Spain, United States, Canada, China, Germany, India, Japan, Mexico, South Africa, Turkey, Poland, Saudi Arabia

Search clinical trials for: the split-thickness skin graft （STSG） donor site

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations